{
    "id": 18488,
    "fullName": "TTK C604F",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TTK C604F lies within the protein kinase domain of the Ttk protein (UniProt.org). C604F has been demonstrated to confer resistance to Ttk (Mps) inhibitors (PMID: 26364596), but has not been biochemically characterized and therefore, its effect on Ttk protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7272,
        "geneSymbol": "TTK",
        "terms": [
            "TTK",
            "CT96",
            "ESK",
            "MPH1",
            "MPS1",
            "MPS1L1",
            "PYT"
        ]
    },
    "variant": "C604F",
    "createDate": "02/23/2016",
    "updateDate": "10/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 122049,
        "transcript": "NM_003318",
        "gDna": "chr6:g.80035304G>T",
        "cDna": "c.1811G>T",
        "protein": "p.C604F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4705,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated resistance to inhibition by AZ3146 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 3117,
                "therapyName": "AZ3146",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4715,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated resistance to inhibition by MPI-0479605 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 3458,
                "therapyName": "MPI-0479605",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4708,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated resistance to inhibition by MPS1-IN-3 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 3455,
                "therapyName": "MPS1-IN-3",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4701,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated resistance to inhibition by NMS-P715 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 3107,
                "therapyName": "NMS-P715",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4693,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated resistance to inhibition by Cpd-5 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 3465,
                "therapyName": "Cpd-5",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4710,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a tumor cell line expressing TTK C604F demonstrated high sensitivity to inhibition by reversine in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18830,
                "profileName": "TTK C604F"
            },
            "therapy": {
                "id": 2327,
                "therapyName": "Reversine",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18830,
            "profileName": "TTK C604F",
            "profileTreatmentApproaches": [
                {
                    "id": 7880,
                    "name": "Reversine",
                    "profileName": "TTK C604F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 122050,
            "transcript": "XM_011536099",
            "gDna": "chr6:g.80035304G>T",
            "cDna": "c.1811G>T",
            "protein": "p.C604F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122049,
            "transcript": "NM_003318",
            "gDna": "chr6:g.80035304G>T",
            "cDna": "c.1811G>T",
            "protein": "p.C604F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}